These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review. Tiniakou E; Mammen AL Clin Rev Allergy Immunol; 2017 Feb; 52(1):20-33. PubMed ID: 26429706 [TBL] [Abstract][Full Text] [Related]
45. Rheumatologists' adherence to guidelines for misoprostol use in patients at high risk for nonsteroidal antiinflammatory drug gastropathy. Cibere J; Sibley JT; Haga M J Rheumatol; 2002 Feb; 29(2):339-46. PubMed ID: 11838854 [TBL] [Abstract][Full Text] [Related]
46. Services for spondyloarthritis: a survey of patients and rheumatologists. Derakhshan MH; Pathak H; Cook D; Dickinson S; Siebert S; Gaffney K; Rheumatology (Oxford); 2018 Jun; 57(6):987-996. PubMed ID: 29529295 [TBL] [Abstract][Full Text] [Related]
47. Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis. Ceribelli A; Isailovic N; De Santis M; Generali E; Fredi M; Cavazzana I; Franceschini F; Cantarini L; Satoh M; Selmi C Clin Rheumatol; 2017 Feb; 36(2):469-475. PubMed ID: 27761751 [TBL] [Abstract][Full Text] [Related]
48. Clinical spectrum of inflammatory myositis in South India--a ten year study. Porkodi R; Shanmuganandan K; Parthiban M; Madhavan R; Rajendran P J Assoc Physicians India; 2002 Oct; 50():1255-8. PubMed ID: 12568209 [TBL] [Abstract][Full Text] [Related]
49. [Acquired inflammatory myopathies: interest of specific autoantibodies for their classification]. Benveniste O Rev Prat; 2015 May; 65(5):607-12. PubMed ID: 26165090 [TBL] [Abstract][Full Text] [Related]
50. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies]. Allenbach Y; Benveniste O Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286 [TBL] [Abstract][Full Text] [Related]
51. Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes. Selva-O'Callaghan A; Ros J; Gil-Vila A; Vila-Pijoan G; Trallero-Araguás E; Pinal-Fernandez I Neuromuscul Disord; 2019 Nov; 29(11):819-825. PubMed ID: 31635909 [TBL] [Abstract][Full Text] [Related]
52. Development and validation of a rheumatologist satisfaction with practice scale: The rheumatologist satisfaction scale. Sheth K; Valenzuela A; Shoor S; Ritter PL; Lorig K Medicine (Baltimore); 2019 Nov; 98(48):e18114. PubMed ID: 31770236 [TBL] [Abstract][Full Text] [Related]
53. Use of musculoskeletal ultrasound in Japan: a survey of practicing rheumatologists. Takase K; Ohno S; Ideguchi H; Takeno M; Shirai A; Ishigatsubo Y Mod Rheumatol; 2010 Aug; 20(4):376-80. PubMed ID: 20352465 [TBL] [Abstract][Full Text] [Related]
54. New approaches to the assessment and treatment of the idiopathic inflammatory myopathies. Miller FW Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i82-5. PubMed ID: 22460145 [TBL] [Abstract][Full Text] [Related]
56. Factors that impact decision making among rheumatologists in the initiation of treatment for hypertension in rheumatoid arthritis. Nguyen-Oghalai TU; Hunnicutt SE; Smith ST; Maganti R; McNearney TA J Clin Rheumatol; 2007 Dec; 13(6):307-12. PubMed ID: 18176137 [TBL] [Abstract][Full Text] [Related]
58. The overall and temporal association of cancer with polymyositis and dermatomyositis. Zantos D; Zhang Y; Felson D J Rheumatol; 1994 Oct; 21(10):1855-9. PubMed ID: 7837150 [TBL] [Abstract][Full Text] [Related]
59. [Autoantibody profile in myositis]. Allenbach Y; Benveniste O Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952 [TBL] [Abstract][Full Text] [Related]
60. Survey of rheumatologists on the use of the Philippine Guidelines on the Screening for Tuberculosis prior to use of Biologic Agents. Aquino-Villamin M; Tankeh-Torres S; Lichauco JJ Int J Rheum Dis; 2016 Nov; 19(11):1126-1131. PubMed ID: 26545293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]